Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.
 

RSS icon
Thumbnail

FDA approves empagliflozin for treating chronic kidney disease

The popular SGLT2 inhibitor, sold by Boehringer Ingelheim and Eli Lilly and Company under the name Jardiance, has already been approved by the FDA to treat type 2 diabetes and heart failure.

Thumbnail

Long-term cannabis use may not increase heart attack risk, new study finds—but many questions remain

Access to cannabis is skyrocketing across the United States, but much more research is still needed on its long-term side effects. 

Thumbnail

Low-cost generic programs offer CVD medications at affordable prices—but availability changes from one to the next

Programs managed by H-E-B, Kroger, Mark Cuban Cost Plus Drug Company and Walmart appear to offer the most options for CVD patients. When it comes to AFib and heart failure, however, researchers believe the choices could be improved. 

cardiologist preparing to perform radiofrequency ablation

Another long-term benefit of AFib ablation: Improved mental health

A new study published in JAMA suggests catheter ablation can help AFib patients experience fewer feelings of depression and anxiety.

doctor with overweight patient who may be treated with TAVR or surgery

American College of Cardiology targets preventable heart disease with new screening campaign

The ACC has joined forces with Amgen and Esperion Therapeutics to increase LDL screening in patients with and without a history of cardiovascular issues.

Medtronic faces lawsuit for sharing data of customers who used the InPen smartphone app

Medtronic faces class-action lawsuit after patient data shared with Google, other third-party sites

The complaint describes Medtronic's actions as “immoral, unethical, oppressive and unscrupulous.”

doctor with overweight patient who may be treated with TAVR or surgery

Deaths from obesity-related CVD have skyrocketed in US, especially among Black adults

According to a new analysis of more than 280,000 deaths, the number of obesity-related cardiovascular deaths in the United States tripled from 1999 to 2020. 

money maze payment reimbursement

Weight loss drug semaglutide linked to better heart health, but high costs may limit its impact

It could cost more than $1 million just to avoid a single heart attack, stroke or cardiovascular death, researchers wrote. 

Displaying 137 - 144 of 1152

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.